Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-01 Purchase | 2026-05-05 4:15 pm | Avalyn Pharma Inc. | AVLN | Novo Holdings A/S 10% Owner | 555,555 | $18 | $9,999,990 | 3,883,289 (Direct) | View |
| 2026-05-01 Purchase | 2026-05-01 6:50 pm | Avalyn Pharma Inc. | AVLN | Carroll Jill Director | 277,778 | $18 | $5,000,004 | 2,186,562 (Indirect) | View |
| 2026-05-01 Purchase | 2026-05-01 6:46 pm | Avalyn Pharma Inc. | AVLN | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 555,555 | $18 | $9,999,990 | 1,122,087 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-01 Conversion | 2026-05-05 4:15 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | Novo Holdings A/S 10% Owner | 67,359,071 | $0 | 3,883,289 (Direct) | View |
| 2026-05-01 Conversion | 2026-05-05 08:37 am | N/A N/A | Avalyn Pharma Inc. | AVLN | FMR LLC See Remark 1 10% Owner | 2,284,535 | $0 | 2,284,535 (Indirect) | View |
| 2026-04-29 Option Award | 2026-05-04 06:01 am | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Golden Adam H. General Counsel | 254,891 | $0 | 254,891 (Direct) | View |
| 2026-05-01 Conversion | 2026-05-01 6:50 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | Carroll Jill Director | 38,637,064 | $0 | 2,186,562 (Indirect) | View |
| 2026-05-01 Conversion | 2026-05-01 6:46 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 55,237,877 | $0 | 1,122,087 (Indirect) | View |
| 2026-04-29 Option Award | 2026-05-01 6:32 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Congleton Jon Director | 26,978 | $0 | 26,978 (Direct) | View |
| 2026-04-29 Option Award | 2026-05-01 6:29 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Turner Heather D Director | 26,978 | $0 | 26,978 (Direct) | View |
| 2026-04-29 Option Award | 2026-05-01 6:28 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Rhodes Melissa Chief Operating Officer | 211,975 | $0 | 211,975 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-01 6:27 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Carlson Douglas R Chief Financial Officer | 211,975 | $0 | 211,975 (Direct) | View |
| 2026-04-29 Option Award | 2026-05-01 6:27 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Haviland Kate Director | 26,978 | $0 | 26,978 (Direct) | View |
| 2026-05-01 Conversion | 2026-05-01 6:26 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 25,818,034 | $0 | 1,275,486 (Direct) | View |
| 2026-04-29 Option Award | 2026-05-01 6:26 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Lazarus Howard Chief Medical Officer | 211,975 | $0 | 211,975 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-01 6:26 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Lavelle Erin Director | 26,978 | $0 | 26,978 (Direct) | View |
| 2026-04-29 Option Award | 2026-05-01 6:25 pm | N/A 2036-04-28 | Avalyn Pharma Inc. | AVLN | Baranowski Lyn Chief Executive Officer | 501,033 | $0 | 501,033 (Direct) | View |
Ownership | 2026-04-29 9:57 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 0 | $0 | 1,275,486 (Direct) | View |
Ownership | 2026-04-29 8:53 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | Novo Holdings A/S 10% Owner | 0 | $0 | 3,327,734 (Direct) | View |
Ownership | 2026-04-29 8:44 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | FMR LLC See Remark 1 10% Owner | 0 | $0 | 2,284,535 (Indirect) | View |
Ownership | 2026-04-29 7:08 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 0 | $0 | 2,753,094 (Indirect) | View |
Ownership | 2026-04-29 6:53 pm | N/A N/A | Avalyn Pharma Inc. | AVLN | Carroll Jill Director | 0 | $0 | 1,908,784 (Indirect) | View |
Ownership | 2026-04-29 6:47 pm | N/A 2034-07-23 | Avalyn Pharma Inc. | AVLN | Lavelle Erin Director | 0 | $0 | 43,928 (Direct) | View |
Ownership | 2026-04-29 6:43 pm | N/A 2036-04-02 | Avalyn Pharma Inc. | AVLN | Congleton Jon Director | 0 | $0 | 43,928 (Direct) | View |
Ownership | 2026-04-29 6:36 pm | N/A 2034-01-25 | Avalyn Pharma Inc. | AVLN | Rhodes Melissa Chief Operating Officer | 0 | $0 | 295,061 (Direct) | View |
Ownership | 2026-04-29 6:32 pm | N/A 2034-10-29 | Avalyn Pharma Inc. | AVLN | Turner Heather D Director | 0 | $0 | 64,919 (Direct) | View |
Ownership | 2026-04-29 6:27 pm | N/A 2034-01-24 | Avalyn Pharma Inc. | AVLN | Lazarus Howard Chief Medical Officer | 0 | $0 | 295,062 (Direct) | View |
Ownership | 2026-04-29 6:26 pm | N/A 2036-03-08 | Avalyn Pharma Inc. | AVLN | Haviland Kate Director | 0 | $0 | 43,928 (Direct) | View |
Ownership | 2026-04-29 6:25 pm | N/A 2034-06-10 | Avalyn Pharma Inc. | AVLN | Carlson Douglas R See Remarks | 0 | $0 | 354,074 (Direct) | View |
Ownership | 2026-04-29 6:23 pm | N/A 2032-11-17 | Avalyn Pharma Inc. | AVLN | Baranowski Lyn Chief Executive Officer | 0 | $0 | 1,499,081 (Direct) | View |